What question did this study set out to answer?

This research aims to determine the role of transcription factor ZHX2 in enhancing retinoic acid efficacy in neuroblastoma.

May 6, 2026

Transcription factor zinc fingers and homeoboxes protein 2 (ZHX2) drives CRABP1 targeting to strengthen retinoic acid sensitivity and potentiate therapeutic response in neuroblastoma.

View Full Paper

Ask AI

Bookmark

Authors

Key transcription factors improve retinoic acid efficacy in neuroblastoma, suggesting ZHX2's role in treatment outcomes.

This research aims to determine the role of transcription factor ZHX2 in enhancing retinoic acid efficacy in neuroblastoma.
Identified ZHX2 as a key transcription factor via RNA-seq analysis of RA-treated neuroblastoma cell lines.
Analyzed correlations of ZHX2 with neuroblastoma prognosis using TARGET and GEO databases.
Assessed effects of ZHX2 knockdown/overexpression on neuroblastoma cell proliferation, migration, and apoptosis.
Conducted bioinformatic analysis and verified ZHX2's downstream targets using PCR and histopathology.
ZHX2 influences neuroblastoma sensitivity to retinoic acid, with lower expression linked to poor patient prognosis.
Overexpression of ZHX2 reduced neuroblastoma malignancy and increased apoptosis.
ZHX2 enhanced retinoic acid effects by repressing CRABP1, improving neuronal differentiation and reducing tumor growth.

Wang et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark